Ken Takasawa
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Artificial Intelligence top 10%
- Cancer Research
- Health Informatics top 2%
- Co-authors
- Ryuji HamamotoMasaaki KomatsuSyuzo KanekoKen AsadaKazuma KobayashiNorio ShinkaiSatoshi TakahashiAmina Bolatkan
- Topics
- Epigenetics and DNA Methylation (8 papers)Cancer Genomics and Diagnostics (6 papers)Pluripotent Stem Cells Research (5 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Ken Takasawa
25 papers receiving 636 citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 264
- Radiology, Nuclear Medicine and Imaging 188
- Artificial Intelligence 142
- Cancer Research 123
- Health Informatics 78
Countries citing papers authored by Ken Takasawa
This map shows the geographic impact of Ken Takasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Takasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Takasawa more than expected).
Fields of papers citing papers by Ken Takasawa
This network shows the impact of papers produced by Ken Takasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Takasawa. The network helps show where Ken Takasawa may publish in the future.
Co-authorship network of co-authors of Ken Takasawa
This figure shows the co-authorship network connecting the top 25 collaborators of Ken Takasawa. A scholar is included among the top collaborators of Ken Takasawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Takasawa. Ken Takasawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | Comparison of Vision Transformers and Convolutional Neural Networks in Medical Image Analysis: A Systematic Reviewbreakdown → | 58 |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 9 | |
| 9 | 21 | |
| 10 | 31 | |
| 11 | 36 | |
| 12 | 11 | |
| 13 | 18 | |
| 14 | 62 | |
| 15 | 71 | |
| 16 | 16 | |
| 17 | 21 | |
| 18 | 28 | |
| 19 | 9 | |
| 20 | 28 |
About Ken Takasawa
Ken Takasawa is a scholar working on Health Informatics, Cancer Research and Molecular Biology, having authored 27 papers that have together received 652 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (6 papers) and Pluripotent Stem Cells Research (5 papers). The work is most often cited by research in Health Informatics (78 citations), Cancer Research (123 citations) and Radiology, Nuclear Medicine and Imaging (188 citations). Ken Takasawa has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Ryuji Hamamoto, Masaaki Komatsu, Syuzo Kaneko, Ken Asada, Kazuma Kobayashi, Norio Shinkai, Satoshi Takahashi, Amina Bolatkan, Hidenori Machino and Ryo Shimoyama. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.